| 000 | 01602 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512002859.0 | ||
| 264 | 0 | _c19891120 | |
| 008 | 198911s 0 0 ger d | ||
| 022 | _a0935-8943 | ||
| 024 | 7 |
_a10.1055/s-2007-998369 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScherlacher, A | |
| 245 | 0 | 0 |
_a[Factors modifying remission in cytostatic chemotherapy of squamous cell carcinoma recurrence in the area of the head and neck]. _h[electronic resource] |
| 260 |
_bLaryngo- rhino- otologie _cAug 1989 |
||
| 300 |
_a425-32 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPalliative Care |
| 650 | 0 | 4 | _aPrognosis |
| 700 | 1 | _aJakse, R | |
| 700 | 1 | _aLehnert, M | |
| 700 | 1 | _aHaas, J | |
| 773 | 0 |
_tLaryngo- rhino- otologie _gvol. 68 _gno. 8 _gp. 425-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2007-998369 _zAvailable from publisher's website |
| 999 |
_c2483001 _d2483001 |
||